Skip to main content

EL PAPEL DE LOS FACTORES DE REGULACION MIOGENICA SOBRE LA DIVERSIDAD MUSCULAR DURANTE EL DESARROLLO Y EN EL ADULTO

PID2020-117058GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RIO. Repositorio Institucional Olavide
Publication Artículo científico (JournalArticle)

Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease

  • Hernández Camacho, Juan Diego|||0000-0001-9726-6726
  • Vicente-Garcia, Cristina
  • Ardilla-Garcia, Lorena
  • Padilla-Campos, Ana
  • López-Lluch, Guillermo|||0000-0001-9830-8502
  • Santos-Ocaña, Carlos|||0000-0002-2379-796X
  • Zammit, Peter
  • Carvajal, Jaime|||0000-0002-7277-0317
  • Navas, Plácido|||0000-0002-4115-7966
  • Moreno Fernández-Ayala, Daniel José|||0000-0001-8176-1431
Background ADCK genes encode aarF domain-containing mitochondrial kinases involved in coenzyme Q (CoQ) biosynthesis and regulation. Haploinsufficiency of ADCK2 in humans leads to adult-onset physical incapacity with reduced mitochondrial CoQ levels in skeletal muscle, resulting in mitochondrial myopathy and alterations in fatty acid β-oxidation. The sole current treatment for CoQ deficiencies is oral administration of CoQ10, which causes only partial recovery with postnatal treatment, underscoring the importance of early diagnosis for successful intervention. Methods We used Adck2 heterozygous mice to examine the influence of this gene on muscle structure, function and regeneration throughout development, growth and ageing. This investigation involved techniques including immunohistochemistry, analysis of CoQ levels, mitochondrial respiratory content, muscle transcriptome analysis and functional tests. Results We demonstrated that Adck2 heterozygous mice exhibit defects from embryonic development, particularly in skeletal muscle (1102 genes deregulated). Adck2 heterozygous embryos were 7% smaller in size and displayed signs of delayed development. Prenatal administration of CoQ10 could mitigate these embryonic defects. Heterozygous Adck2 mice also showed a decrease in myogenic cell differentiation, with more severe consequences in ‘aged’ mice (41.63% smaller) (P < 0.01). Consequently, heterozygous Adck2 mice displayed accelerated muscle wasting associated with ageing in muscle structure (P < 0.05), muscle function (less grip strength capacity) (P < 0.001) and muscle mitochondrial respiration (P < 0.001). Furthermore, progressive CoQ10 administration conferred protective effects on mitochondrial function (P < 0.0001) and skeletal muscle (P < 0.05). Conclusions Our work uncovered novel aspects of CoQ deficiencies, revealing defects during embryonic development in mammals for the first time. Additionally, we identified the gradual establishment and progression of the deleterious Adck2 mouse phenotype. Importantly, CoQ10 supplementation demonstrated a protective effect when initiated during development.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of myogenic gene expression

  • Vicente-García, Cristina
  • Hernández-Camacho, Juan Diego
  • Carvajal, Jaime J.
Skeletal muscle development and regeneration is governed by the combined action of Myf5, MyoD, Mrf4 and MyoG, also known as the myogenic regulatory factors (MRFs). These transcription factors are expressed in a highly spatio-temporal restricted manner, ensuring the significant functional and metabolic diversity observed between the different muscle groups. In this review, we will discuss the multiple layers of regulation that contribute to the control of the exquisite expression patterns of the MRFs in particular, and of myogenic genes in general. We will highlight all major regulatory processes that play a role in myogenesis: from those that modulate chromatin status and transcription competence, such as DNA methylation, histone modification, chromatin remodeling, or non-coding RNAs, to those that control transcript and protein processing and modification, such as alternative splicing, polyadenylation, other mRNA modifications, or post-translational protein modifications. All these processes are exquisitely and tightly coordinated to ensure the proper activation, maintenance and termination of the myogenic process., This work was supported by the Association Française contre les Myopathies (AFM) through fellowship grant #22450 to C.V.-G., by the Spanish Ministry of Education, Culture and Sports through fellowship FPU16/03264 to J.D.H.C., as well as by an Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD), an AFM research grant #22447, and PID2020-117058GB-I00 from the Spanish Ministry of Science and Innovation to J.J.C.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

NMJ-related diseases beyond the congenital myasthenic syndromes

  • Navarro-Martínez, Alejandra
  • Vicente-García, Cristina
  • Carvajal, Jaime J.
Neuromuscular junctions (NMJs) are a special type of chemical synapse that transmits electrical stimuli from motor neurons (MNs) to their innervating skeletal muscle to induce a motor response. They are an ideal model for the study of synapses, given their manageable size and easy accessibility. Alterations in their morphology or function lead to neuromuscular disorders, such as the congenital myasthenic syndromes, which are caused by mutations in proteins located in the NMJ. In this review, we highlight novel potential candidate genes that may cause or modify NMJs-related pathologies in humans by exploring the phenotypes of hundreds of mouse models available in the literature. We also underscore the fact that NMJs may differ between species, muscles or even sexes. Hence the importance of choosing a good model organism for the study of NMJ-related diseases: only taking into account the specific features of the mammalian NMJ, experimental results would be efficiently translated to the clinic., This work was funded by the Spanish Ministry of Education, Culture and Sports through fellowship PRE2019-091097 to AN-M, an Institutional Grant CEX2020-001088-M (Maria de Maeztu Ecellence Unit, Department of Gene Regulation and Morphogenesis at CABD), an AFM research grant #22447, and PID2020-117058GB-I00 from the Spanish Ministry of Science and Innovation to JC, and ProyExcel_00153 from the Andalusian Government Junta de Andalucia (PAIDI 2020; 2021 call) to CV-G., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001088-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease

  • Hernández-Camacho, Juan Diego
  • Vicente-García, Cristina
  • Ardila-García, Lorena
  • Padilla-Campos, Ana
  • López-Lluch, Guillermo
  • Santos-Ocaña, Carlos
  • Zammit, Peter
  • Carvajal, Jaime J.
  • Navas, Plácido
  • Fernández-Ayala, Daniel J. M.
[Background]: ADCK genes encode aarF domain-containing mitochondrial kinases involved in coenzyme Q (CoQ) biosynthesis and regulation. Haploinsufficiency of ADCK2 in humans leads to adult-onset physical incapacity with reduced mitochondrial CoQ levels in skeletal muscle, resulting in mitochondrial myopathy and alterations in fatty acid β-oxidation. The sole current treatment for CoQ deficiencies is oral administration of CoQ10, which causes only partial recovery with postnatal treatment, underscoring the importance of early diagnosis for successful intervention., [Methods]: We used Adck2 heterozygous mice to examine the influence of this gene on muscle structure, function and regeneration throughout development, growth and ageing. This investigation involved techniques including immunohistochemistry, analysis of CoQ levels, mitochondrial respiratory content, muscle transcriptome analysis and functional tests., [Results]: We demonstrated that Adck2 heterozygous mice exhibit defects from embryonic development, particularly in skeletal muscle (1102 genes deregulated). Adck2 heterozygous embryos were 7% smaller in size and displayed signs of delayed development. Prenatal administration of CoQ10 could mitigate these embryonic defects. Heterozygous Adck2 mice also showed a decrease in myogenic cell differentiation, with more severe consequences in ‘aged’ mice (41.63% smaller) (P < 0.01). Consequently, heterozygous Adck2 mice displayed accelerated muscle wasting associated with ageing in muscle structure (P < 0.05), muscle function (less grip strength capacity) (P < 0.001) and muscle mitochondrial respiration (P < 0.001). Furthermore, progressive CoQ10 administration conferred protective effects on mitochondrial function (P < 0.0001) and skeletal muscle (P < 0.05)., [Conclusions]: Our work uncovered novel aspects of CoQ deficiencies, revealing defects during embryonic development in mammals for the first time. Additionally, we identified the gradual establishment and progression of the deleterious Adck2 mouse phenotype. Importantly, CoQ10 supplementation demonstrated a protective effect when initiated during development., This research was funded by the Instituto de Salud Carlos III (PI20/00541) co-funded by the European Regional Development Fund ‘A way to make Europe’. This work was supported by the Spanish Ministry of Education, Culture and Sports through Fellowship FPU16/03264 to JDH-C, an Institutional Grant CEX2020-001088-M (María de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and PID2020-117058GB-I00 from the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación) to JC, and ProyExcel_00153 from the Andalusian Government Junta de Andalucia (PAIDI 2020; 2021 call) to CV-G. Relevant funding for the Zammit lab includes the Medical Research Council (MR/P023215/1 and MR/S002472/1), Friends of FSH Research and the FSHD Society (FSHD-Fall2020-3308289076). Funding for open access publishing: Universidad Pablo de Olavide/CBUA., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001088-M)., Peer reviewed